GSK Prepares For Malaria Vaccine Roll-Out In Africa By 2015
This article was originally published in The Pink Sheet Daily
Executive Summary
“While we have seen some decline in vaccine efficacy over time, the sheer number of children affected by malaria means that the number of cases of the disease the vaccine can help prevent is impressive,” GSK CEO Witty says.